Log In
BCIQ
Print this Print this
 

IBI-20089

  Manage Alerts
Collapse Summary General Information
Company Icon Bioscience Inc.
DescriptionControlled-release formulation of the corticosteroid triamcinolone
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationMacular edema
Indication DetailsTreat cystoid macular edema; Treat cystoid macular edema associated with retinal vein occlusion (RVO)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today